- Q4 2026 core revenue growth including respiratory: approximately 3%.
- Danaher guided fourth-quarter core revenue growth including respiratory of approximately 3%.
Danaher provided Q4 2026 core revenue growth guidance including respiratory of approximately 3%. The figure matches the total-company core growth rate previously guided. Q3 core revenue grew 3% (ex-respiratory 5.5%).
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.